Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: 19F-Tagged metal binding pharmacophores for NMR screening of metalloenzymes
Kathleen E.
Prosser
,
Alysia J.
Kohlbrand
,
Hyeonglim
Seo
,
Mark
Kalaj
and
Seth M.
Cohen
*
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. E-mail: scohen@ucsd.edu
First published on 21st February 2022
Abstract
Correction for ‘19F-Tagged metal binding pharmacophores for NMR screening of metalloenzymes’ by Kathleen E. Prosser et al., Chem. Commun., 2021, 57, 4934–4937, DOI: 10.1039/D1CC01231B.
The authors regret that the Conflicts of Interest statement in the original manuscript was incomplete. The full Conflicts of Interest statement is as follows:
S. M. C. is a cofounder of and has an equity interest in Cleave Therapeutics, Forge Therapeutics, and Blacksmith Medicines, companies that may potentially benefit from the research results. S. M. C. also serves on the Scientific Advisory Board for Blacksmith Medicines and serves on the Scientific Advisory Board and receives compensation from Forge Therapeutics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2022 |